Back to results
US 9,040,518 B2Granted
Chemical compounds
AssigneeGlaxoSmithKline LLC
InventorsChristopher Joseph Aquino, Jon Loren Collins, David John Cowan, Yulin Wu
Life of this patent
Estimating the term…
Abstract
Compounds of Formula I and methods for treating metabolic disorders are disclosed.
Claims22
A compound of Formula I
- wherein R1 is H, Cl, Br, N(CH3)2, or methoxy;
- R2 is H or OH;
- each R3 is independently C1-6alkyl;
- X is CH2, C(O), or CH═CH;
- Q is C0-6alkyl;
- R4 is OH, SO3H, CO2H, PO3H2, CONR5R5, NR5R5;
- or NHC(O)CH2NR5R5;
- each R5 is independently H, OH, C1-6alkyl, C0-6alkylCO2H, C0-6 alkylSO3H, C0-6alkylPO3H2, C(O)C0-6alkylCO2H, C(O)C0-6alkylSO3H, C(O)C0-6alkylPO3H2, or CH(R7)C0-6alkyCO2H;
- and
- R7 is C0-6alkylCO2H, C0-6alkylOH, C0-6alkylSO3H, or C0-6alkylPO3H2.
7 more elements
The compound
The compound
Dependencies are inferred from the claim text.